Foley T P, Klein A H, Foley B, Agustin A V, MacDonald H M, Hopwood N, Postellon D C
Fortschr Med. 1979 Feb 8;97(6):221-4.
14,919 newborn infants were screened for congenital hypothyroidism within the last 5 years using a sensitive TSH method. 10 infants with congenital hypothyroidism were discovered thus presenting a frequency of 1:4500. Four of these infants showed abnormally high TSH levels and normal thyroxine levels. The determination of TSH in cord blood--or combined with the screening program for phenylketonuria--in eluate of dried filter paper specimens is the most sensitive test for primary hypothyroidism without false negative results and a low false positive recall rate of 0.16%. After initiation of therapy with thyroxine the TSH level falls unless therapy is delayed for longer. In the latter case TSH levels may remain elevated for several months despite therapy with thyroxine. We would suggest to start therapy with triiodothyronine for up to 14 days prior to initiation of the usual thyroxine therapy.
在过去5年中,我们使用灵敏的促甲状腺激素(TSH)检测方法对14919例新生儿进行了先天性甲状腺功能减退症筛查。共发现10例先天性甲状腺功能减退症患儿,发病率为1:4500。其中4例患儿促甲状腺激素水平异常升高而甲状腺素水平正常。脐血促甲状腺激素测定——或与苯丙酮尿症筛查项目相结合,采用干滤纸标本洗脱液检测——是原发性甲状腺功能减退症最灵敏的检测方法,无假阴性结果,假阳性召回率低,为0.16%。开始使用甲状腺素治疗后,促甲状腺激素水平会下降,除非治疗延迟。在后一种情况下,尽管使用了甲状腺素治疗,但促甲状腺激素水平可能会持续升高数月。我们建议在开始常规甲状腺素治疗前14天内先使用三碘甲状腺原氨酸进行治疗。